Abstract
The bioequivalence of two formulations of the same drug may be determined by evaluating the similarity of their respective plasma concentration curves. The similarity of two plasma concentration functions can be measured by an index called the bioequivalence index. This paper shows how such an index may be defined and calculated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
U.S. Food and Drug Administration. Bioavailability and bioequivalence requirements. Fed. Regist. 42:1638–1653 (1977).
C. M. Metzler. Bioavailability—a problem in equivalence. Biometrics 30:309–317 (1974).
C. M. Metzler. Equivalence of bioavailability and efficacy in drug testing. In A. Pecile and A. Rescigno (eds.), Pharmacokinetics: Mathematical and Statistical Approaches to Metabolism and Distribution of Chemicals and Drugs, Plenum Press, New York, 1988, pp. 215–225.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rescigno, A. Bioequivalence. Pharm Res 9, 925–928 (1992). https://doi.org/10.1023/A:1015809201503
Issue Date:
DOI: https://doi.org/10.1023/A:1015809201503